Showing results (11-20 of 129) with videos related to
Sort By:
Pageof 13
Nutrients|April 3, 2021
Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together?Marta Ziemińska, Beata Sieklucka, Krystyna PawlakPolskie Archiwum Medycyny Wewnetrznej|June 2, 2006
[Hepatocyte growth factor (HGF) in stable and unstable coronary heart disease]Waldemar Kazberuk, Krystyna Pawlak, Michał MyśliwiecBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 22, 2007
Association between tissue factor, its pathway inhibitor and oxidative stress in peritoneal dialysis patientsKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecNephron. Clinical Practice|August 3, 2007
Erythropoietin therapy decreased tissue factor, its pathway inhibitor, and oxidative stress in peritoneal dialysis patients with diabetesKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecThrombosis Research|July 29, 2014
oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patientsKrystyna Pawlak, Michal Mysliwiec, Dariusz PawlakClinical Biochemistry|January 25, 2015
Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular diseaseKrystyna Pawlak, Michal Mysliwiec, Dariusz PawlakNephron|July 26, 2002
Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patientsJacek Borawski, Krystyna Pawlak, Michał MyśliwiecThrombosis Research|June 21, 2005
Oxidative stress effects fibrinolytic system in dialysis uraemic patientsKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecAmerican Journal of Nephrology|March 27, 2007
Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patientsKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecAmerican Journal of Nephrology|January 4, 2005
Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular diseaseKrystyna Pawlak, Dariusz Pawlak, Michal MysliwiecPageof 13